Reliability and validity of the Tibetan version of the International Prostate Symptom Score
- PMID: 37039905
- DOI: 10.1007/s00345-023-04368-1
Reliability and validity of the Tibetan version of the International Prostate Symptom Score
Abstract
Objective: To validate the Tibetan version of the International Prostate Symptom Score (IPSS-Tib) in patients with and without urinary symptoms in a Tibetan population.
Methods: The validity and reliability of IPSS-Tib were studied in 85 patients with benign prostatic hyperplasia (BPH) and 62 controls without lower urinary tract symptoms (LUTS). Reliability was evaluated using the test-retest method and internal consistency using Cronbach's α, and the construct validity was assessed by the correlation between IPSS-Tib scores and quality of life questions (QoL-Tib).
Results: The Cronbach's α coefficient of the IPSS-Tib was 0.80 and of a single IPSS scoring item ranged from 0.77 to 0.86. The IPSS-Tib test-retest reliability was evaluated by the intraclass correlation coefficient, and its average value was 0.79 (P < 0.001). The mean (SEM, 95% CI) area under the ROC curve for the IPSS-Tib was 0.91 (0.87-0.96). The IPSS-Tib had a high correlation with the QoL-Tib (Spearman's rank correlation coefficient 0.84, P < 0.01). The mean IPSS score before transurethral resection of the prostate (TURP) was 21.9 (6.8), and dropped to 6.38 (1.54) after TURP (P < 0.001), and the average difference was 15.52 (6.23), related to the drop from 4.5 (0.9) to 1.46 (0.48) in the QoL (P < 0.001).
Conclusion: The IPSS-Tib has good reliability and validity in the diagnosis and symptom severity assessment of patients with BPH in Tibetan areas. It is an ideal assessment tool that can be used in Tibetan-speaking areas for patients with BPH and as a method for evaluating postoperative curative effect assessment of patients with BPH.
Keywords: Altitude; Benign prostatic hyperplasia; Lower urinary tract symptoms; Prostate; Tibet.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Development and validation of an Arabic version of the International Prostate Symptom Score.BJU Int. 2010 May;105(10):1434-8. doi: 10.1111/j.1464-410X.2009.08984.x. Epub 2009 Oct 26. BJU Int. 2010. PMID: 19863520
-
Validation of the Arabic linguistic version of the Danish Prostatic Symptom Score for benign prostatic hyperplasia associated with lower urinary tract symptoms.Arab J Urol. 2021 Feb 20;19(4):464-468. doi: 10.1080/2090598X.2021.1892291. eCollection 2021. Arab J Urol. 2021. PMID: 34881063 Free PMC article.
-
The visual prostate symptom score is a simple tool to identify and follow up in general practice patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (a study with 1359 patients).Presse Med. 2018 Jul-Aug;47(7-8 Pt 1):e91-e98. doi: 10.1016/j.lpm.2018.06.011. Epub 2018 Jul 31. Presse Med. 2018. PMID: 30075950
-
Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia.Health Technol Assess. 2005 Feb;9(4):iii-iv, 1-30. doi: 10.3310/hta9040. Health Technol Assess. 2005. PMID: 15698525 Review.
-
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.Cochrane Database Syst Rev. 2018 Nov 16;11(11):CD010060. doi: 10.1002/14651858.CD010060.pub2. Cochrane Database Syst Rev. 2018. PMID: 30480763 Free PMC article.
References
-
- Chughtai B, Forde JC, Thomas DD et al (2016) Benign prostatic hyperplasia. Nat Rev Dis Primers 2:16031. https://doi.org/10.1038/nrdp.2016.31 - DOI - PubMed
-
- Sarma AV, Wei JT (2012) Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med 367(3):248–257. https://doi.org/10.1056/NEJMcp1106637 - DOI - PubMed
-
- McVary KT, Roehrborn CG, Avins AL et al (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5):1793–1803. https://doi.org/10.1016/j.juro.2011.01.074 - DOI - PubMed
-
- Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic Obstruction. Eur Urol 67(6):1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038 - DOI - PubMed
-
- Badía X, García-Losa M, Dal-Ré R, Carballido J, Serra M (1998) Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symptom Score. Urology Spanish version 52(4):614–620. https://doi.org/10.1016/s0090-4295(98)00204-0 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical